BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38065734)

  • 1. The high expression of TOP2A indicates poor prognosis and is associated with immune infiltration in kidney renal clear cell carcinoma.
    Song S; Lou K; Lun J; Cui Y
    Asian J Surg; 2024 Mar; 47(3):1493-1494. PubMed ID: 38065734
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial Comment to Contact with renal sinus is associated with poor prognosis in surgically treated pT1 clear cell renal cell carcinoma.
    Teishima J
    Int J Urol; 2020 Aug; 27(8):662. PubMed ID: 32578259
    [No Abstract]   [Full Text] [Related]  

  • 3. Lower mRNA and protein expression levels of LC3 and Beclin1, markers of autophagy, were correlated with progression of renal clear cell carcinoma.
    Deng Q; Wang Z; Wang L; Zhang L; Xiang X; Wang Z; Chong T
    Jpn J Clin Oncol; 2013 Dec; 43(12):1261-8. PubMed ID: 24186908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An
    Fu S; Gong B; Ding Y; Zhuang C; Chen Q; Wang S; Li Z; Ma M; Liu Y; Zhang Z; Sun T
    Comb Chem High Throughput Screen; 2022; 25(13):2278-2294. PubMed ID: 35293292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DAB2IP Plays Important Clinical Significance and Correlates With Immune Infiltration in Renal Cell Carcinoma.
    Cao H; Zhang J; Wang W
    Technol Cancer Res Treat; 2020; 19():1533033820936682. PubMed ID: 32583730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher Serum C-reactive Protein Level Represents the Immunosuppressive Tumor Microenvironment in Patients With Clear Cell Renal Cell Carcinoma.
    Nakayama T; Saito K; Kumagai J; Nakajima Y; Kijima T; Yoshida S; Kihara K; Fujii Y
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1151-e1158. PubMed ID: 30213543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comprehensive analysis of essential meiotic endonuclease 1 to prognosis and immune infiltration in kidney renal clear cell carcinoma.
    Li HD; Ma HX; Ma JH; Kong SP; Zhao ST; Fan SQ; Qin F; Ma JG
    Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):584-602. PubMed ID: 38305603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
    Sun K; Chen RX; Li JZ; Luo ZX
    Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Urinary Collecting System Invasion is Associated with Poor Survival in Patients with Clear-Cell Renal Cell Carcinoma.
    Laguna MP
    J Urol; 2017 Nov; 198(5):976-978. PubMed ID: 29059769
    [No Abstract]   [Full Text] [Related]  

  • 10. [Renal cell carcinoma in the solitary kidney].
    Kagawa S; Takigawa H; Aga Y; Sumiyoshi Y; Imagawa A; Yuasa M; Numata A; Terao N
    Hinyokika Kiyo; 1988 Apr; 34(4):619-22. PubMed ID: 3400545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zeta-crystallin serves as a prognostic biomarker for patients with kidney renal clear cell carcinoma.
    Shi X; Feng D; Han P; Wei W
    Asian J Surg; 2023 Jul; 46(7):2894-2895. PubMed ID: 36805722
    [No Abstract]   [Full Text] [Related]  

  • 12. LRP6 is a potential biomarker of kidney clear cell carcinoma related to prognosis and immune infiltration.
    Lu L; Lei Y; Li Y; Wang L
    Aging (Albany NY); 2024 Jan; 16(2):1484-1495. PubMed ID: 38226972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A neutrophil-related prognostic index for patients with kidney renal clear-cell carcinoma.
    Guo YQ; Yu QX; Li DX; Zheng HH
    Asian J Surg; 2023 Jun; 46(6):2390-2392. PubMed ID: 36621424
    [No Abstract]   [Full Text] [Related]  

  • 14. Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma.
    Jiang H; Chen H; Wan P; Chen N
    Genomics; 2021 Nov; 113(6):3556-3564. PubMed ID: 34391866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
    Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Hepcidin expression predicts poor prognosis in patients with clear cell renal cell carcinoma.
    Tang Y; Ge S; Zheng X; Zheng J
    Diagn Pathol; 2022 Dec; 17(1):100. PubMed ID: 36585741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "To Cut or Not to Cut", a Biomolecular Approach to Metastasectomy in Metastatic Clear Cell Renal Cell Carcinoma.
    Bracarda S; Guida A; Caserta C
    Eur Urol; 2018 Oct; 74(4):481-482. PubMed ID: 30029820
    [No Abstract]   [Full Text] [Related]  

  • 18. Survival benefit of pancreatic metastasectomy of clear cell renal cell carcinoma.
    Fang Y; Tang M; Zhou WT; Lou WH
    Chin Med J (Engl); 2019 Nov; 132(22):2751-2753. PubMed ID: 31765357
    [No Abstract]   [Full Text] [Related]  

  • 19. [Case of renal cell carcinoma in a horseshoe kidney].
    Kato M; Uchida J; Iwai T; Deguchi T; Nishihara C; Ninomiya N; Kawashima H; Nakatani T
    Hinyokika Kiyo; 2008 Nov; 54(11):723-5. PubMed ID: 19068726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Prognostic Impact of a Positive Vascular Margin on pT3 Clear Cell Renal Cell Carcinoma.
    Liu NW; Wren JD; Vertosick E; Lee JK; Power NE; Benfante NE; Kimm SY; Bains MS; Sjoberg DD; Russo P; Coleman JA
    J Urol; 2016 Feb; 195(2):264-9. PubMed ID: 26363467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.